triazoles has been researched along with peptide yy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gillespie, DG; Jackson, EK; Kochanek, SJ | 1 |
| Adrian, TE; Bilchik, AJ; Modlin, IM; Nilsson, O; Sussman, J; Zucker, KA | 1 |
| Aaboe, K; Deacon, CF; Holst, JJ; Knop, FK; Krarup, T; Madsbad, S; Vilsbøll, T | 1 |
| Barrett, DG; Beavers, LS; Briere, DA; Coskun, T; Dubois, SL; Efanov, AM; Franciskovich, JB; Michael, MD; O'Farrell, LS; Syed, SK | 1 |
| Apseloff, G; Atiee, G; Bush, MA; Collins, DA; Corsino, L; Feldman, PL; Gillmor, D; McMullen, SL; Morrow, L; Nunez, DJ | 1 |
| Aratsu, Y; Hamada, H; Ishii, Y; Kakutani, M; Kume, S; Nishiu, J; Oda, T; Ohe, Y; Ohta, T; Okuma, C; Oshida, S; Tadaki, H; Taniuchi, H; Yamanaka, K; Yata, S | 1 |
2 trial(s) available for triazoles and peptide yy
| Article | Year |
|---|---|
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Metformin; Middle Aged; Peptide YY; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2010 |
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Male; Mesylates; Metformin; Middle Aged; Oxadiazoles; Peptide YY; Prognosis; Pyrazines; Receptors, G-Protein-Coupled; Sitagliptin Phosphate; Triazoles | 2014 |
4 other study(ies) available for triazoles and peptide yy
| Article | Year |
|---|---|
Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
Topics: Animals; Arginine; Cell Proliferation; Cells, Cultured; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Glomerular Mesangium; Glucagon-Like Peptide 1; Male; Models, Animal; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptide YY; Proline; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sitagliptin Phosphate; Thymidine; Triazoles | 2012 |
H2-receptor blockade induces peptide YY and enteroglucagon-secreting gastric carcinoids in mastomys.
Topics: Animals; Carcinogens; Carcinoid Tumor; Gastric Mucosa; Gastrointestinal Hormones; Glucagon-Like Peptides; Histamine H1 Antagonists; Hyperplasia; Muridae; Peptide YY; Peptides; Reference Values; Stomach; Stomach Neoplasms; Triazoles | 1989 |
Activation of prostaglandin E receptor 4 triggers secretion of gut hormone peptides GLP-1, GLP-2, and PYY.
Topics: Animals; Cells, Cultured; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Intestinal Mucosa; Mice; Peptide YY; Real-Time Polymerase Chain Reaction; Receptors, Prostaglandin E, EP4 Subtype; Thiophenes; Triazoles | 2013 |
JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity.
Topics: Acyltransferases; Animals; Body Weight; Chlorocebus aethiops; COS Cells; Diet, High-Fat; Eating; Glucose Tolerance Test; Humans; Intestinal Absorption; Lipid Metabolism; Male; Mice; Obesity; Oxygen Consumption; Peptide YY; Piperazines; Rats; Triazoles | 2015 |